Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Amoretti

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Journal of Clinical Medicine|May 1, 2019
Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and ReliabilitySilvia Amoretti, Bibiana Cabrera, Carla Torrent, et al.
Journal of Clinical Medicine|July 2, 2021
The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of PsychosisMariola Molina-García, David Fraguas, Ángel Del Rey-Mejías, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 16, 2024
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up studyDerek Clougher, Maria Florencia Forte, Gisela Mezquida, et al.
Schizophrenia Research|December 3, 2023
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinationsGracian Garcia-Marti, Maria J Escarti, Juan Nacher, et al.
Spanish Journal of Psychiatry and Mental Health|November 16, 2025
From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypesAnaid Pérez-Ramos, Àlex Gonzalez-Segura, Laura Julià, et al.
Schizophrenia Research|September 26, 2022
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burdenManuel J Cuesta, Alejandro Ballesteros, Ana M Sánchez-Torres, et al.
Psychoneuroendocrinology|August 6, 2024
Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episodeTeresa Jordà-Baleri, Marina Garriga, Gisela Mezquida, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 5, 2024
The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysisDerek Clougher, Àlex G Segura, Maria F Forte, et al.
Spanish Journal of Psychiatry and Mental Health|September 16, 2023
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patientsGisela Mezquida, Silvia Amoretti, Miquel Bioque, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 10, 2022
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up studyAna M Sánchez-Torres, Silvia Amoretti, Mónica Enguita-Germán, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Journal of Clinical Medicine|May 1, 2019
Cognitive Reserve Assessment Scale in Health (CRASH): Its Validity and ReliabilitySilvia Amoretti, Bibiana Cabrera, Carla Torrent, et al.
Journal of Clinical Medicine|July 2, 2021
The Role of Premorbid IQ and Age of Onset as Useful Predictors of Clinical, Functional Outcomes, and Recovery of Individuals with a First Episode of PsychosisMariola Molina-García, David Fraguas, Ángel Del Rey-Mejías, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 16, 2024
Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up studyDerek Clougher, Maria Florencia Forte, Gisela Mezquida, et al.
Schizophrenia Research|December 3, 2023
Progressive loss of cortical gray matter in first episode psychosis patients with auditory hallucinationsGracian Garcia-Marti, Maria J Escarti, Juan Nacher, et al.
Spanish Journal of Psychiatry and Mental Health|November 16, 2025
From premorbid adjustment dimensions to clinical outcomes: Exploring environmental stress and epigenetic influences on first-episode schizophrenia phenotypesAnaid Pérez-Ramos, Àlex Gonzalez-Segura, Laura Julià, et al.
Schizophrenia Research|September 26, 2022
Relapse of first-episode schizophrenia patients and neurocognitive impairment: The role of dopaminergic and anticholinergic burdenManuel J Cuesta, Alejandro Ballesteros, Ana M Sánchez-Torres, et al.
Psychoneuroendocrinology|August 6, 2024
Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episodeTeresa Jordà-Baleri, Marina Garriga, Gisela Mezquida, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 5, 2024
The role of cognitive reserve and clinical symptoms in the association between genetic liability for educational attainment and functioning in first-episode psychosis: A mediation analysisDerek Clougher, Àlex G Segura, Maria F Forte, et al.
Spanish Journal of Psychiatry and Mental Health|September 16, 2023
Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patientsGisela Mezquida, Silvia Amoretti, Miquel Bioque, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 10, 2022
Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up studyAna M Sánchez-Torres, Silvia Amoretti, Mónica Enguita-Germán, et al.
Pageof 12